Ovarian aging and systemic health: Mechanisms and emerging intervention strategies

Ying Jing1, Jing Qu2, Si Wang3

  • 1Advanced Innovation Center for Human Brain Protection, National Clinical Research Center for Geriatric Disorders, Aging Translational Medicine Center, Beijing Municipal Geriatric Medical Research Center, Beijing Key Laboratory of Environment and Aging, Xuanwu Hospital Capital Medical University, Beijing 100053, China.

Cell Stem Cell
|August 17, 2026
PubMed

Insights

Ovarian aging contributes to systemic aging through cellular defects and hormonal changes. Interventions targeting the ovaries may preserve fertility and extend healthspan by combating aging processes.

Area of Science:

  • Reproductive biology
  • Gerontology
  • Endocrinology

Background:

  • Ovarian aging is increasingly recognized as a potential driver of systemic aging.
  • Cellular intrinsic defects within the ovary may initiate aging signals.
  • Estrogen decline from ovarian aging significantly impacts overall physiology.

Purpose of the Study:

  • To review the intrinsic cellular defects in ovarian aging.
  • To explore the link between ovarian aging and systemic aging.
  • To discuss potential interventions for ovarian aging and its systemic effects.

Main Methods:

  • Literature review of ovarian aging mechanisms.
  • Analysis of cellular defects (genomic instability, epigenetics, mitochondrial damage, proteostasis).
  • Examination of senescence-associated secretory phenotype (SASP)-related inflammaging and fibrosis.

Main Results:

  • Ovarian aging involves genomic instability, epigenetic alterations, mitochondrial dysfunction, and proteostasis issues.
  • These defects can lead to inflammaging, fibrosis, and pro-aging signals.
  • Estrogen decline is a key endocrine disruption affecting multiple bodily systems.

Conclusions:

  • Ovarian aging contributes to systemic aging and age-related multimorbidity in females.
  • Ovary-targeted interventions, including senolytics and regenerative medicine, show promise.
  • Preserving ovarian function may extend healthspan and improve quality of life.

Related Concept Videos

Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...